As of 2026-09-15, the Relative Valuation of Theravance Biopharma Inc (TBPH) is 19.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.03 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is 15.0%.
The range of the Relative Valuation is 14.36 - 29.92 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 7.7x | 7.1x |
| Forward P/E multiples | 7.0x - 12.3x | 9.6x |
| Fair Price | 14.36 - 29.92 | 19.58 |
| Upside | -15.7% - 75.7% | 15.0% |
| Date | P/E |
| 2026-09-11 | 7.70 |
| 2026-09-10 | 7.70 |
| 2026-09-09 | 7.72 |
| 2026-09-08 | 7.72 |
| 2026-09-04 | 7.73 |
| 2026-09-03 | 7.73 |
| 2026-09-02 | 7.72 |
| 2026-09-01 | 7.71 |
| 2026-08-31 | 7.71 |
| 2026-08-28 | 7.72 |
| 2026-08-27 | 7.71 |
| 2026-08-26 | 7.71 |
| 2026-08-25 | 7.71 |
| 2026-08-24 | 7.70 |
| 2026-08-21 | 7.70 |
| 2026-08-20 | 7.67 |
| 2026-08-19 | 7.69 |
| 2026-08-18 | 7.67 |
| 2026-08-17 | 7.66 |
| 2026-08-14 | 7.68 |
| 2026-08-13 | 7.66 |
| 2026-08-12 | 7.66 |
| 2026-08-11 | 7.66 |
| 2026-08-10 | 7.65 |
| 2026-08-07 | 7.66 |
| 2026-08-06 | 7.66 |
| 2026-08-05 | 7.65 |
| 2026-08-04 | 7.64 |
| 2026-08-03 | 7.63 |
| 2026-07-31 | 7.63 |
| 2026-07-30 | 7.62 |
| 2026-07-29 | 7.62 |
| 2026-07-28 | 7.64 |
| 2026-07-27 | 7.63 |
| 2026-07-24 | 7.63 |
| 2026-07-23 | 7.63 |
| 2026-07-22 | 7.61 |
| 2026-07-21 | 7.62 |
| 2026-07-20 | 7.61 |
| 2026-07-17 | 7.66 |
| 2026-07-16 | 7.68 |
| 2026-07-15 | 7.66 |
| 2026-07-14 | 7.66 |
| 2026-07-13 | 7.65 |
| 2026-07-10 | 7.66 |
| 2026-07-09 | 7.68 |
| 2026-07-08 | 7.69 |
| 2026-07-07 | 7.70 |
| 2026-07-06 | 7.69 |
| 2026-07-02 | 7.66 |